BLY-32142-75361
3 vaccinations
8 coded responses
41 check-ins
8 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 46-50
- ZIP prefix
- 982 / WA
- Registered
- 2021-04-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-20
Registered in v-safe
-
2021-04-20
Dose 1 — Moderna
-
2021-04-20
Health check-in — day 0, dose 1Feeling: Poor · Site: Itching · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-21
- 2021-04-22
- 2021-04-23
- 2021-04-24
- 2021-04-25
- 2021-04-26
- 2021-04-27
- 2021-05-05
- 2021-05-11
-
2021-05-18
Dose 2 — Moderna
-
2021-05-18
Survey response — day 0, dose 2MedDRA: Brain fog — Feeling: Poor · Site: Pain, Redness, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessFree text: Brain fogMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-19
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-05-20
- 2021-05-21
- 2021-05-22
-
2021-05-23
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-05-24
- 2021-05-25
- 2021-06-01
- 2021-06-08
- 2021-06-15
- 2021-06-23
- 2021-06-29
- 2021-08-17
-
2021-11-16
Survey response — 6 months, dose 2MedDRA: Exposure to SARS-CoV-2, Productive cough, Secretion discharge — Feeling: GoodFree text: Mucous coughs; extremely more frequently than before COVID-19 exposure & didn't start until after.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-22
Dose 3 — Moderna
- 2021-11-22
-
2021-11-23
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-11-24
Health check-in — days 1–6 daily, dose 3Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-11-25
- 2021-11-26
- 2021-11-27
- 2021-11-28
- 2021-11-29
-
2021-12-06
Survey response — day 14, dose 3MedDRA: Cough, Discomfort, Increased upper airway secretion, Respiratory tract congestion — Feeling: GoodFree text: Hyper mucous secretion from throat/lungs. Discomfort from congestion with cough. No fever, no headache, no fatigue. Persistent cough.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-13
Survey response — day 21, dose 3MedDRA: Productive cough, Secretion discharge — Feeling: GoodFree text: Excessive mucous in bronchial tubes causing frequent productive coughs.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-20
Survey response — day 28, dose 3MedDRA: Cough, Lower respiratory tract congestion — Feeling: GoodFree text: Persistent cough and excessive mucous in bronchial tubes.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-27
Survey response — day 35, dose 3MedDRA: Cough, Secretion discharge — Feeling: GoodFree text: Persistent excessive mucous that causes coughs from bronchial tubes.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-03
Survey response — day 42, dose 3MedDRA: Productive cough, Secretion discharge — Feeling: GoodFree text: Persistent excessive mucous causing productive coughs.MedDRA releases: 2024-11 · check-in free text available
- 2022-02-21
-
2022-05-24
Survey response — 6 months, dose 3MedDRA: Cough, Productive cough — Feeling: GoodFree text: Persistent mucous cough.MedDRA releases: 2024-11 · check-in free text available
- 2022-11-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-20 | Moderna | |
| 2 | 2021-05-18 | Moderna | |
| 3 | 2021-11-22 | Moderna | No |
Free text
Release 8 — day 0, dose 2
Systemic reaction (other): Brain fog
Release 10 — 6 months, dose 2
Symptoms: Mucous coughs; extremely more frequently than before COVID-19 exposure & didn't start until after.
Release 10 — day 14, dose 3
Symptoms: Hyper mucous secretion from throat/lungs. Discomfort from congestion with cough. No fever, no headache, no fatigue. Persistent cough.
Release 10 — day 21, dose 3
Symptoms: Excessive mucous in bronchial tubes causing frequent productive coughs.
Release 10 — day 28, dose 3
Symptoms: Persistent cough and excessive mucous in bronchial tubes.
Release 10 — day 35, dose 3
Symptoms: Persistent excessive mucous that causes coughs from bronchial tubes.
Release 10 — day 42, dose 3
Symptoms: Persistent excessive mucous causing productive coughs.
Release 11 — 6 months, dose 3
Symptoms: Persistent mucous cough.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Discomfort | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Increased upper airway secretion | · | · | ✓ |
| SD | Lower respiratory tract congestion | · | · | ✓ |
| SD | Productive cough | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Secretion discharge | · | · | ✓ |
| SRO | Brain fog | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release